KairoRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.4/10
Best for: people who want compounded GLP-1s alongside peptide and hormone treatments from one telehealth brand
KairoRx scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
then $199/mo ongoing
Tirzepatide
then $349/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
KairoRx is a telehealth brand launched in 2026 that lists compounded semaglutide and tirzepatide alongside peptide, hormone and longevity treatments. Its pricing page shows semaglutide at $49 for the first month, then $199 a month, and tirzepatide at $99, then $349 a month. The online form ends with a promise of follow-up rather than a checkout, and the company does not name its medical group or pharmacies.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to KairoRx
Editorial score · methodology
Editorial score · methodology
Sprout Health
Best for: LegitScript-certified compounded GLP-1 via named pharmacies
Editorial score · methodology
KairoRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Ozempic, Zepbound
- Starting price
- $49/mo
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How we scored KairoRx
Each dimension is scored algorithmically from KairoRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.8/10At $199/mo, KairoRx runs about 17% above the $170 median for GLP-1 providers, and the first month drops to $49.
Effectiveness25%
7.4/10KairoRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
6.4/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.5/10KairoRx's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.2/10Coaching/dietitian access included.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this KairoRx review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $65–$349/mo across 4 dose/plan tiers — checked October 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with KairoRx
We walked KairoRx’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Get Started opens one long health form: height, weight, goal weight, sex, date of birth, two condition checklists, opioid use, surgery, medications, blood pressure and heart rate
- 2A testimonial video screen and a screen explaining that your provider sets the dosing pace
- 3Questions about weight-loss medicine in the past 4 weeks, past diet programs and other interests
- 4A summary with your BMI, then a contact form asking for name, email, phone and state
- 5Two agreement checkboxes for accurate answers and the terms; the walk stopped here, before submitting
- Prices are on the pricing and treatment pages, but the form itself never shows a plan, a price or a payment step
- After you agree, the form ends with a message that the team will follow up by email or text
- The weight-loss page lists $149 injections, $249 tablets and a $99 brand membership, which differ from the pricing page
- The quarterly semaglutide plan is $249 a month, higher than the $199 monthly plan
- No card details are requested, so nothing can be charged during sign-up
- We did not take the medication; nothing here describes a patient outcome
KairoRx customer support
- Phone
- (201) 751-9896
GLP-1 medications KairoRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$49 first month, then $199 a month. A quarterly plan is listed at $747 per quarter ($249 a month)
$99 first month, then $349 a month. A quarterly plan is listed at $897 per quarter ($299 a month)
$65 a month covers the provider review, titration and care-team support; the pharmacy bills the medication on top
$65 a month covers the provider review, titration and care-team support; the pharmacy bills the medication on top
Ready to get started?
Plans and promotions change often — check KairoRx's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide and tirzepatide prices are listed on the site before you start
- You are not charged until a provider approves a plan, according to its terms and FAQ
- Compounded plans include provider messaging, coaching and free shipping, with no membership fee
- Brand-name Ozempic and Zepbound are available for a $65 monthly access fee plus the medication cost
- Full refund if you cancel within 14 days of the first charge and the pharmacy has not yet prepared your order
- Publishes a support phone number, and HSA or FSA cards are accepted
Watch-outs
- The site does not name the company behind it, its medical group or the pharmacies that fill prescriptions
- The online form ends with a promise that the team will follow up by email or text, with no plan choice or checkout
- The weight-loss page shows different prices ($149 injections, $99 brand membership) that it calls illustrative
- After the $49 or $99 first month, semaglutide renews at $199 and tirzepatide at $349 a month
- The quarterly semaglutide plan costs $249 a month, more than the $199 monthly plan it is promoted against
- The site launched in 2026 yet claims 12,000+ members, a 4.8 rating and press coverage we could not trace
- There is no Trustpilot profile and no LegitScript certification
- The list of states it serves is not published
Is KairoRx worth it?
What KairoRx is selling, in one line, is people who want compounded GLP-1s alongside peptide and hormone treatments from one telehealth brand. New patients start at $49/month for the first month, but the price steps up to $199/month once that window ends — so treat the headline number as an intro offer, not the standing rate. Coaching and follow-up are part of the package, not an upsell.
Beyond the medication itself, KairoRx charges no membership fee and takes HSA/FSA payment.
How much KairoRx actually costs
- Compounded semaglutide starts at $49 the first month, then $199/month after that, at that tier.
- Compounded tirzepatide starts at $99 the first month, then $349/month after that, for that option.
- Brand-name semaglutide runs $65/month, if you go that route.
- Brand-name tirzepatide runs $65/month, at that tier.
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month. KairoRx's standing rate sits at the premium end of that range, well above the cheapest options in the category. The first-month discount is a great way to start cheaply. Still, price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against KairoRx before you commit.
Medications: what KairoRx prescribes
KairoRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Pick the brand-name pen for the FDA-approved product, or the compounded version to cut the monthly cost — the compounded trade-off being that it isn't FDA-approved as a finished formulation.
Who KairoRx is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
KairoRx is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $49 intro price steps up to $199/month once the first month is behind you. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, HumeCare+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
KairoRx scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with KairoRx?
Starting at $49/month. See current pricing and start your free consultation.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this KairoRx review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See KairoRx's current pricing
Plans start at $49/month. Start your free consultation to check eligibility and today's price.